Opportunities in India’s TB Diagnostics Markets: Price and Market Trend Analysis

$ 350.00

Globally, India has the second highest TB burden as per WHO ranking. The country is witnessing a growing demand for advanced tests for early TB diagnosis. This is driving the TB diagnostics market in India and is also creating new opportunities for diagnostic companies with effective platforms. Drug resistance is a particular concern in TB and the demand is high for diagnostic tools that can quickly and accurately diagnose drug resistant TB.

This price analysis and market intelligence report studies the opportunities offered by India’s TB diagnostics markets.

Description


  • Globally, India has the second highest TB burden as per WHO ranking. The country is witnessing a growing demand for advanced tests for early TB diagnosis. This is driving the TB diagnostics market in India and is also creating new opportunities for diagnostic companies with effective platforms. Drug resistance is a particular concern in TB and the demand is high for diagnostic tools that can quickly and accurately diagnose drug resistant TB.

    India is witnessing an increase in the uptake of advanced TB diagnostic products. In spite of being a price sensitive market, several expensive diagnostic tests have achieved significant market penetration in India lately. Creative business strategies are being designed and implemented by market players. This is creating an environment where industry players are encouraged to invest in the development of TB diagnostics. This is an important market trend considering the fact that TB had not been one of the major infectious diseases to attract industrial investments.

    This price analysis and market intelligence report studies the opportunities offered by India’s TB diagnostics markets. Emerging trends in TB diagnosis, impact of regulations, influence of various initiatives, end-user preferences, and pricing trends of key diagnostic products are studied in detail. The insights derived are presented in clear and lucid manner.

    This report offers detailed analysis of the price trends and the factors impacting the pricing of these tools. A particular emphasis is given for PCR-based diagnostic products as these are gaining considerable market shares in this segment. Overall, this report contains:

    • An overview of TB diagnostic technologies and trends in India and worldwide
    • An overview of various initiatives that are impacting the TB diagnostic practices in India
    • An overview of the diagnostic products available in India and their manufacturers
    • Detailed product profiles of some of the promising diagnostic products
    • An in depth analysis of the diagnostic practices of private and public sector healthcare service providers
    • Price trend analysis based on primary research involving around 25 healthcare service providers. The respondents of our survey covered the industry segment from various aspects including public and private healthcare service providers, different geographic locations, urban as well as rural clinics, and big hospitals as well as small diagnostic labs
    • Company profiles of most prominent companies in Indian TB diagnostics segment
  • INTRODUCTION
    STUDY GOAL AND OBJECTIVES
    RATIONALE FOR THIS STUDY
    TARGETED AUDIENCE
    MARKET DEFINITION AND SCOPE
    INFORMATION SOURCES AND METHODOLOGIES
    CUSTOMIZATION OF THIS STUDY
    DISCLAIMER
    EXECUTIVE SUMMARY
    SUMMARY FIGURE: PRICE OF PCR-BASED TESTS IN INDIA – GENEXPERT VS NON-GENEXPERT TESTS *

    OVERVIEW

    TUBERCULOSIS IN INDIA – INCIDENCE AND PREVALENCE
    Figure 1: TB Incidence and Prevalence in India, 2010-2013

    REGION-WISE TB STATISTICS
    Figure 2: TB Incidence in India, Region-Wise a

    KEY GLOBAL INITIATIVES/PROGRAMS FOR TB CONTROL
    Table 1: Key Programs Targeting Effective TB Control: India and Global

    KEY TB CONTROL INITIATIVES/PROGRAMS IN INDIA
    A. Revised National Tuberculosis Control Program (RNTCP)
    B. Initiative for Promoting Affordable, Quality TB tests (IPAQT)
    Table 2: WHO-Endorsed TB Diagnostic Tests and Their “Ceiling Prices” under the IPAQT Program
    C. Mumbai Mission for TB Control
    D. National Stop TB Partnership – Partnership for TB Care and Control (PTCC)
    Table 3: The Growth of PTCC from Conceptual Stage to Current Status
    E. Project LIGHT
    F. Improved Diagnosis of TB and Drug Resistant TB in the Tibetan Refugee Population in India
    Table 4: TB Control and Diagnosis in India: Milestone Developments

    CLINICAL DIAGNOSIS OF TB: CURRENT STATUS – INDIA AND GLOBAL
    Table 5: Diagnostic Tests for Latent and Active TB
    Molecular approaches for TB diagnosis
    Table 7: Key TB Diagnostics Products in the Market and their Manufacturers*
    Table 8: Desirable Characteristics of POC TB Diagnostic Products
    Table 9: Tests under Development for TB Diagnosis*

    PRODUCT PROFILES

    TB DIAGNOSTICS DEVELOPED IN COLLABORATION WITH FIND
    A. Xpert MTB/RIF
    Table 10: Cumulative Number of GeneXpert Instrument Modules and Xpert MTB/RIF Test Cartridges Procured under Concessional Pricing per Year, Globally
    B. Genotype MTBDRplus
    Figure 3: Annual Manufacturing Capacity and Prices of Genotype MTBDRplus Test
    C. BACTEC MGIT Systems

    PCR FOR TB DIAGNOSIS: ANALYSIS OF PRICING TRENDS

    SELECTION OF STUDY PARTICIPANTS/METHODOLOGY
    Table 11: Details of the Laboratories Selected for the Study

    PRICES AT WHICH VARIOUS PCR-BASED TB DIAGNOSTIC TESTS ARE OFFERED IN INDIA

    IMPACT OF IPAQT INITIATIVE IN IMPROVING AFFORDABILITY OF TB DIAGNOSTICS
    Table 12: Price Range of PCR-based Tests – GeneXpert vs Non-GeneXpert tests (USD; Per Test) a
    Figure 4: Price of PCR-based Tests in India – GeneXpert vs Non-GeneXpert Tests
    Table 13: Number of PCR-Based TB Tests Conducted per Month
    Table 14: List of IPAQT Member Laboratories in India a
    Figure 5: Number of IPAQT Member Laboratories in Each Region in India

    COMPANY PROFILES

    COMPANIES OFFERING COMMERCIALIZED PRODUCTS FOR TB DIAGNOSIS
    Merck Specialities Private Limited-Genei
    (Previously known as Bangalore Genei (India) Private Limited)
    bigtec Labs Pvt. Ltd.
    Cepheid, Inc.
    Table 15: Clinical and Non-Clinical Revenue Shares, 2014
    Figure 6: Cepheid Revenue Shares, by Region, 2014
    Hain Lifescience GmbH
    Table 16: TB diagnostic Products Offered by Hain Lifescience
    Professional Biotech Pvt. Ltd./ Genome Diagnostics Pvt. Ltd.
    Molbio Diagnostics Pvt. Ltd (A Tulip Group Company)

    REFERENCES

    GLOSSARY

    List of Tables
    Table 1: Key Programs Targeting Effective TB Control: India and Global
    Table 2: WHO-Endorsed TB Diagnostic Tests and Their “Ceiling Prices” under the IPAQT Program
    Table 3: The Growth of PTCC from Conceptual Stage to Current Status
    Table 4: TB Control and Diagnosis in India: Milestone Developments
    Table 5: Diagnostic Tests for Latent and Active TB
    Table 6: Advantages and Disadvantages of Selected TB Diagnostics
    Table 7: Key TB Diagnostics Products in the Market and their Manufacturers*
    Table 8: Desirable Characteristics of POC TB Diagnostic Products
    Table 9: Tests under Development for TB Diagnosis*
    Table 10: Cumulative Number of GeneXpert Instrument Modules and Xpert MTB/RIF Test Cartridges Procured under Concessional Pricing per Year, Globally
    Table 11: Details of the Laboratories Selected for the Study
    Table 12: Price Range of PCR-based Tests – GeneXpert vs Non-GeneXpert tests (USD; Per Test) a
    Table 13: Number of PCR-Based TB Tests Conducted per Month
    Table 14: List of IPAQT Member Laboratories in India a
    Table 15: Clinical and Non-Clinical Revenue Shares, 2014
    Table 16: TB diagnostic Products Offered by Hain Lifescience

    List of Figures
    Figure 1: TB Incidence and Prevalence in India, 2010-2013
    Figure 2: TB Incidence in India, Region-Wise a
    Figure 3: Annual Manufacturing Capacity and Prices of Genotype MTBDRplus Test
    Figure 4: Price of PCR-based Tests in India – GeneXpert vs Non-GeneXpert Tests
    Figure 5: Number of IPAQT Member Laboratories in Each Region in India
    Figure 6: Cepheid Revenue Shares, by Region, 2014

  • Companies offering commercialized products for TB diagnosis

    1. Merck Specialities Private Limited-Genei (Previously known as Bangalore Genei (India) Private Limited)
    2. bigtec Labs Pvt. Ltd.
    3. Cepheid, Inc.
    4. Hain Lifescience GmbH
    5. Professional Biotech Pvt. Ltd./ Genome Diagnostics Pvt. Ltd
    6. Molbio Diagnostics Pvt. Ltd (A Tulip Group Company)